# Immunopharmacological Effects of Rituximab in Atopic Dermatitis

> **NCT00267826** · NA · COMPLETED · sponsor: **University of Bern** · enrollment: 6 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT00267826
- **Lead sponsor:** University of Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2006-06
- **Final completion:** 2006-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2008-06-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00267826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00267826, "Immunopharmacological Effects of Rituximab in Atopic Dermatitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00267826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*